6:15 PM
 | 
Dec 18, 2012
 |  BC Extra  |  Top Story

Sutro, Celgene in antibody deal

Sutro Biopharma Inc. (South San Francisco, Calif.) partnered with Celgene Corp. (NASDAQ:CELG) to design and develop antibody-drug conjugates (ADCs) and bispecific antibodies for two undisclosed targets from Celgene for undisclosed...

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >